Report of Repeat Specimens Submitted - Newborn Bloodspot Screening Program - Maine

Report of Repeat Specimens Submitted - Newborn Bloodspot Screening Program is a legal document that was released by the Maine Department of Health and Human Services - a government authority operating within Maine.

FAQ

Q: What is the Newborn Bloodspot Screening Program in Maine?
A: The Newborn Bloodspot Screening Program in Maine is a program that screens newborns for certain genetic, metabolic, and endocrine disorders.

Q: Why are repeat specimens submitted for the Newborn Bloodspot Screening Program?
A: Repeat specimens are submitted for the Newborn Bloodspot Screening Program to confirm or rule out the presence of specific disorders.

Q: Who submits the repeat specimens for the Newborn Bloodspot Screening Program?
A: The repeat specimens for the Newborn Bloodspot Screening Program are typically submitted by healthcare providers or hospitals.

Q: What are some of the disorders screened for in the Newborn Bloodspot Screening Program?
A: The Newborn Bloodspot Screening Program in Maine screens for disorders such as phenylketonuria (PKU), congenital hypothyroidism, sickle cell disease, and cystic fibrosis.

Q: How are the repeat specimens collected for the Newborn Bloodspot Screening Program?
A: The repeat specimens for the Newborn Bloodspot Screening Program are collected through a blood spot obtained from a baby's heel.

Q: What happens if a disorder is detected during the Newborn Bloodspot Screening Program?
A: If a disorder is detected during the Newborn Bloodspot Screening Program, further testing and follow-up will be recommended to confirm the diagnosis and provide appropriate treatment.